Ledger.Open graph →
SEC Form D · filed March 13, 2019

Gila Therapeutics, Inc

Offering
$2.0M
Sold
$314K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Minneapolis, MN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Jon J. Freeman · Minneapolis, MNExecChristopher J. De Souza · Minneapolis, MNDirectorRichard J. Horan · Minneapolis, MNDirectorThomas J. Vasicek · Minneapolis, MNExec · Director · PromoterJames Geiskopf · LOS ANGELES, CADirectorEdmund B. Moy · LOS ANGELES, CADirectorSteve Jaffee · Cincinnati, OHExecNick Parkes · Luxembourg, LuxembourgDirectorDavid Redmond · Luxembourg, LuxembourgDirectorMatthew Perelman · NEW YORK, NYExecThomas J. Vasicek · Minneapolis, MNExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗